[{"id":"e7e0f9e8-9fa6-4272-881b-3d9ac0112ada","acronym":"BMX-GyCa-001","url":"https://clinicaltrials.gov/study/NCT06620029","created_at":"2025-02-26T15:00:07.320Z","updated_at":"2025-02-26T15:00:07.320Z","phase":"Phase 1/2","brief_title":"BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer","source_id_and_acronym":"NCT06620029 - BMX-GyCa-001","lead_sponsor":"BioMimetix JV, LLC","biomarkers":" BCL2 • TNFA","pipe":"","alterations":" ","tags":["BCL2 • TNFA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e paclitaxel • BMX-001"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 27","initiation":"Initiation: 04/01/2025","start_date":" 04/01/2025","primary_txt":" Primary completion: 03/31/2027","primary_completion_date":" 03/31/2027","study_txt":" Completion: 07/31/2027","study_completion_date":" 07/31/2027","last_update_posted":"2024-10-01"}]